EGFR immunoexpression, RAS immunoexpression and their effects on survival in lung adenocarcinoma cases

Gundogdu A. G., Onder S., Firat P., DOĞAN R.

JOURNAL OF THORACIC DISEASE, vol.6, no.6, pp.778-784, 2014 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 6 Issue: 6
  • Publication Date: 2014
  • Doi Number: 10.3978/j.issn.2072-1439.2014.04.35
  • Journal Name: JOURNAL OF THORACIC DISEASE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.778-784
  • Keywords: Lung adenocarcinoma, epidermal growth factor receptor (EGFR), RAS, survival, GROWTH-FACTOR RECEPTOR, ONCOGENE PRODUCT, PROGNOSTIC VALUE, CANCER, EXPRESSION, MUTATIONS, FREQUENT, MARKERS
  • Hacettepe University Affiliated: Yes

Abstract

Background: The impacts of epidermal growth factor receptor (EGFR) immunoexpression and RAS immunoexpression on the survival and prognosis of lung adenocarcinoma patients are debated in the literature.